本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ReShape Lifesciences, Inc.

0.3832
+0.073523.73%
盘后0.40890.0257+6.71%18:21 EDT
成交量:1.52亿
成交额:6,566.98万
市值:432.11万
市盈率:-0.03
高:0.4925
开:0.4613
低:0.3723
收:0.3097
数据加载中...
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/21

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/20

重要事件披露

Form 8-K - Current report
2025/02/21

重要事件披露

Form 8-K - Current report
2025/02/15

SEC问询函

Form CORRESP - Correspondence
2025/02/14

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/14

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/14

SEC问询函

Form CORRESP - Correspondence
2025/02/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/13

SEC问询函

Form CORRESP - Correspondence
2025/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/21

重要事件披露

Form 8-K - Current report
2025/01/21

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/01/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/15

SEC问询函

Form CORRESP - Correspondence
2024/12/27

重要事件披露

Form 8-K - Current report
2024/12/20

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933